• Keytruda-Chemo Combo Shows Superior Anti-cancer Response in Metastatic NSCLC Phase 3 Trial
  • Men, Women Respond Differently to Immunotherapies Used in Advanced Cancer Treatment, Study Shows
  • Apogenix Updates Data on Asunercept, Prepares Submission for Conditional Marketing Authorization in Europe
  • Immunotherapy Targeting Tumor Mutations Leads to Complete Response in Advanced Breast Cancer Patient, NIH Reports
  • Foundation Medicine and Merck Collaborating to Develop Diagnostic Tests for Keytruda
  • Imfinzi Improves Survival of Patients with Advanced Non-small Cell Lung Cancer, Phase 3 Trial Shows
  • Tecentriq with Avastin and Chemotherapy Prolongs Life of Patients with Metastatic Lung Cancer, Phase 3 Study Shows
  • 1st Patient Treated in Phase 1 Trial of FS118, Potential Immunotherapy for Advanced Cancers
  • First Lung Cancer Patient Treated with NEO-PV-01 Vaccine in Phase 1 Trial
  • Quizartinib Prolongs Survival in Some Patients with Relapsed or Refractory AML, Phase 3 Study Shows
  • Tecentriq-Cotellic Combo Fails to Lengthen Survival in Advanced Colorectal Cancer
  • Phase 1 Trial on Treos’ Potential Colorectal Cancer Vaccine Doses First Patient